alkenes has been researched along with Amyloid Deposits in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (75.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cui, M; Fu, H; Li, Y; Liu, S; Liu, Y; Wan, R; Yan, XX; Yan, Y; Zeng, Q | 1 |
| Burgess, A; Hynynen, K; Klibanov, AL; Moffatt, C; Nhan, T | 1 |
| Becker, K; Dodt, HU; Grathwohl, SA; Jährling, N; Jucker, M; Wegenast-Braun, BM | 1 |
| Komano, H; Maeda, T; Michikawa, M; Zou, K | 1 |
| Hyman, B | 1 |
| Bacskai, BJ; Finn, MB; Garcia-Alloza, M; Holtzman, DM; Hyman, BT; Koenigsknecht-Talboo, J; Meyer-Luehmann, M; Parsadanian, M | 1 |
| Bacskai, BJ; Debnath, ML; Frosch, MP; Holt, DP; Hyman, BT; Kajdasz, ST; Klunk, WE; Mathis, CA; McLellan, ME; Wang, Y | 1 |
| Carp, RI; Debnath, M; Gambetti, P; Gan, WB; Klunk, WE; Li, Y; Mathis, CA; Meeker, HC; Pankiewicz, J; Sadowski, M; Scholtzova, H; Shao, L; Tsai, J; Wisniewski, T | 1 |
| Bales, KR; Fryer, JD; Holtzman, DM; Parsadanian, M; Paul, SM; Simmons, K; Sullivan, PM | 1 |
| Bacskai, BJ; Betensky, RA; Domnitz, SB; Frosch, MP; Garcia-Alloza, M; Greenberg, C; Greenberg, SM; Hyman, BT; Purcell, SM; Rebeck, GW; Robbins, EM | 1 |
| Abrahamson, EE; Debnath, ML; Dekosky, ST; Ikonomovic, MD; Isanski, BA; Klunk, WE; Mathis, CA | 1 |
| Hamilton, RL; Klunk, WE; Styren, GC; Styren, SD | 1 |
1 review(s) available for alkenes and Amyloid Deposits
| Article | Year |
|---|---|
X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Benzoates; Disease Progression; Fluorescent Dyes; Histocytochemistry; Humans; Neurofibrillary Tangles; Plaque, Amyloid | 2006 |
11 other study(ies) available for alkenes and Amyloid Deposits
| Article | Year |
|---|---|
D-π-A-Based Trisubstituted Alkenes as Environmentally Sensitive Fluorescent Probes to Detect Lewy Pathologies.
Topics: Alkenes; alpha-Synuclein; Brain; Fluorescent Dyes; Humans; Parkinson Disease; Plaque, Amyloid | 2022 |
Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.
Topics: Alkenes; Alzheimer Disease; Animals; Benzene Derivatives; Blood-Brain Barrier; Brain; Cerebral Amyloid Angiopathy; Drug Delivery Systems; Female; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence, Multiphoton; Permeability; Plaque, Amyloid; Stilbenes; Ultrasonics | 2014 |
Cerebral β-Amyloidosis in Mice Investigated by Ultramicroscopy.
Topics: Alkenes; Amyloid beta-Protein Precursor; Amyloidosis; Animals; Benzene Derivatives; Brain; Disease Models, Animal; Fluorescent Dyes; Humans; Imaging, Three-Dimensional; Mice, Inbred C57BL; Mice, Transgenic; Microscopy; Plaque, Amyloid; Stilbenes | 2015 |
New amyloid plaques or a game of hide-and-seek?
Topics: Alkenes; Alzheimer Disease; Animals; Benzene Derivatives; Brain; Disease Models, Animal; Mice; Plaque, Amyloid; Stilbenes | 2008 |
In reply to Zou et al. "New amyloid plaques or a game of hide-and-seek?".
Topics: Alkenes; Alzheimer Disease; Animals; Benzene Derivatives; Brain; Disease Models, Animal; Mice; Plaque, Amyloid; Stilbenes | 2008 |
Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice.
Topics: Age Factors; Alkenes; Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Antibodies; Benzene Derivatives; Calcium-Binding Proteins; Cell Count; Cell Movement; Cerebral Amyloid Angiopathy; CX3C Chemokine Receptor 1; Disease Models, Animal; Green Fluorescent Proteins; Leukocyte Common Antigens; Mice; Mice, Transgenic; Microfilament Proteins; Microglia; Plaque, Amyloid; Receptors, Chemokine; Stilbenes | 2008 |
Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzene; Benzene Derivatives; Binding, Competitive; Blood-Brain Barrier; Carbon Radioisotopes; Coloring Agents; Congo Red; Disease Models, Animal; Imaging, Three-Dimensional; Male; Mice; Mice, Transgenic; Microscopy; Peptide Fragments; Plaque, Amyloid; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Stilbenes | 2002 |
Targeting prion amyloid deposits in vivo.
Topics: Alkenes; Amyloid beta-Peptides; Animals; Benzene Derivatives; Brain; Disease Models, Animal; Humans; Metabolic Clearance Rate; Mice; Plaque, Amyloid; Predictive Value of Tests; Prion Diseases; Reproducibility of Results; Scrapie; Stilbenes; Tomography, Emission-Computed | 2004 |
Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Benzoates; Blood Vessels; Cerebral Amyloid Angiopathy; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid | 2005 |
Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzene Derivatives; Cerebral Amyloid Angiopathy; Craniotomy; Disease Models, Animal; Disease Progression; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Kinetics; Meninges; Mice; Mice, Transgenic; Plaque, Amyloid; Skin Window Technique; Stilbenes | 2006 |
X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.
Topics: Aged; Aged, 80 and over; Alkenes; Alzheimer Disease; Amyloid; Amyloidosis; Benzoates; Benzothiazoles; Coloring Agents; Congo Red; Female; Fluorescent Dyes; Histocytochemistry; Humans; Male; Middle Aged; Neurofibrillary Tangles; Plaque, Amyloid; Protein Structure, Secondary; Silver; Thiazoles | 2000 |